Skip to main content
UniHealth

Doctor search

Sally E Boero, MD

Obstetrics/Gynecology · San Francisco

NPI 1285731703

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
11
2 carriers
Office
1
Since medical school
30 years
University of California, Geffen School of Medicine, 1996

Offices

1 location · Regents Univ of California UCSF · 276 clinicians in this group

Looking this up.

Hospitals listed: Marinhealth Medical Center · Novato Community Hospital. That is not proof they admit you there this week.

Plans that list them

11 plans · 2 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Boero’s office at (415) 476-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

11 of 11 plans

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Imperial Courage Plan (HMO)Imperial Health Plan of California, Inc.ListedSep 1, 2026
Imperial Dynamic Plan (HMO)Imperial Health Plan of California, Inc.ListedSep 1, 2026
Imperial Senior Value (HMO C-SNP)Imperial Health Plan of California, Inc.ListedSep 1, 2026

California Medical Board record

Licence A64736 · Current

Licensed to practise in California · since 1998 · expires 2028-04-30 · University of California, Los Angeles School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

School, training and certification

What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.

Specialty certification

  • American Board of Obstetrics and Gynecology - Obstetrics and Gynecology

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Marinhealth Medical CenterGreenbrae, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of MarinHealthPatients rate it 3 of 5 · 76% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.66 (3.59 to 7.73) · 1,505 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.177, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025
  • Novato Community HospitalNovato, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 84% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Marinhealth Medical Center

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 3 better, 8 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Marinhealth Medical Center
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.66 (3.59 to 7.73) · 1,505 casesWorseJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.177BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.85 (0 to 1.83) · 1,056 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.04 (0.72 to 1.36)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths167.34 (112.58 to 222.09) · 57 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.9 · 47 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths8.5 · 119 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.6 · 257 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.5 · 428 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths11.4 · 477 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths9.3 · 197 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.1 · 2,827 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.18 (0 to 0.38) · 6,990 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.21 (0.02 to 0.41) · 6,838 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.41 (0 to 3) · 664 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.86 (1.4 to 4.33) · 1,436 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths10.38 (3.68 to 17.08) · 705 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths4.38 (0.72 to 8.04) · 672 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.66 (0.18 to 3.15) · 300 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.56 (0 to 1.25) · 5,550 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.4 · 76 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.396No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.1 · 275 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits22 · 427 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-20.3 · 289 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits3.3 · 494 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-4.9 · 499 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits17.9 · 435 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.5 (3.6 to 8.4) · 93 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits11.2 (7.8 to 16) · 93 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits6.6 · 84 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.5 · 53 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.3 · 111 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13 (10.3 to 16.5) · 2,119 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1.1 (0.8 to 1.4) · 670 casesNo differentJan 2024 – Dec 2024

What patients said (1,233 patients answered, 19% of those asked)

Patient survey stars by topic at Marinhealth Medical Center
Cleanliness3
Nurse communication3
Doctor communication3
Communication about medicines2
Discharge information3
Overall hospital rating4
Quietness3
Recommend hospital4
Share of patients giving the best answer at Marinhealth Medical Center
Room was "always" clean68%
Nurses "always" communicated well73%
Doctors "always" communicated well74%
Staff "always" explained56%
Yes, staff "did" give patients this information85%
Yes, staff "did" give patients information about help after discharge85%
Doctors "always" explained things so they could understand71%
Doctors "always" listened carefully72%
Doctors "always" treated them with courtesy and respect80%
Patients who gave a rating of "9" or "10" (high)72%
Staff "always" explained new medications70%
Nurses "always" explained things so they could understand68%
Nurses "always" listened carefully68%
Nurses "always" treated them with courtesy and respect82%
"Always" quiet at night48%
"YES", patients would definitely recommend the hospital76%
Staff "always" explained possible side effects43%
Yes, staff "did" give patients information about possible symptoms85%
See every measure and the patient survey for Novato Community Hospital

Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Novato Community Hospital
Clostridium Difficile (C.Diff)Infections0BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths1 (0 to 2.06) · 213 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.85 (0.4 to 1.3)No differentJul 2022 – Jun 2024
Death rate for COPD patientsComplications and deaths8.2 · 25 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths10 · 111 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths16.1 · 140 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths11.3 · 42 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.8 · 627 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.2 (0 to 0.43) · 1,872 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.25 (0.04 to 0.46) · 1,796 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths2.92 (0.5 to 5.33) · 505 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.64 (0 to 3.36) · 317 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.2 (0.51 to 3.88) · 495 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths7.93 (0 to 17.29) · 323 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths4.88 (0.69 to 9.07) · 311 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.75 (0.22 to 3.27) · 96 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.41 (0 to 1.49) · 1,320 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.2 · 143 casesNoneApr 2023 – Mar 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits19.6 · 108 casesNoneJul 2023 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-31.9 · 121 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits1.1 · 150 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.6 · 143 casesNoneJul 2023 – Jun 2025
Rate of readmission after hip/knee replacementUnplanned return visits5.4 · 118 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 27 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.5 (9.5 to 16.5) · 930 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.7 to 1.3) · 184 casesNo differentJan 2024 – Dec 2024

What patients said (334 patients answered, 30% of those asked)

Patient survey stars by topic at Novato Community Hospital
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness3
Recommend hospital5
Share of patients giving the best answer at Novato Community Hospital
Room was "always" clean78%
Nurses "always" communicated well81%
Doctors "always" communicated well83%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand78%
Doctors "always" listened carefully84%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)82%
Staff "always" explained new medications77%
Nurses "always" explained things so they could understand76%
Nurses "always" listened carefully82%
Nurses "always" treated them with courtesy and respect86%
"Always" quiet at night54%
"YES", patients would definitely recommend the hospital84%
Staff "always" explained possible side effects49%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$14,791

Medicare paid this office $14,791 for 121 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Short return visit (20+ min)56$4,491$72
Cervical or vaginal cancer screening; pelvic and clinical breast examination57$2,569$45
Return visit (30+ min)22$2,439$106
Long return visit (40+ min)13$2,427$162
Short return visit19$974$46

Who their Medicare patients are

121 Original Medicare patients in 2024. Average age 73 · Women 100% · Health risk score 0.74. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0.88.

Conditions among them: High blood pressure 36% · Depression 17% · Cancer 15% · Coronary heart disease 10%.

The office billed $77,900, Medicare allowed $19,494 and paid $14,791; for 208 services of 20 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024121208730.74$77,900$14,791
2023118209730.79$96,045$14,621
2022142259730.71$107,162$18,879
202181146740.76$54,844$8,823
2020104164710.64$79,266$8,377
2019120215710.71$95,458$11,455
2018121207710.65$26,682$9,600
2017104226720.83$21,296$9,480
2016115249710.72$26,025$11,620
2015142275720.70$29,178$12,120
2014109233680.76$37,517$14,337
2013125285680.78$30,579$13,746

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 4 services

Original Medicare services billed in 2023
Short return visit (20+ min)61$4,849$67
Return visit (30+ min)25$2,530$94
Cervical or vaginal cancer screening; pelvic and clinical breast examination53$2,382$45
Short return visit16$991$52

2022: 4 services

Original Medicare services billed in 2022
Short return visit (20+ min)67$6,636$81
Cervical or vaginal cancer screening; pelvic and clinical breast examination77$3,404$44
Return visit (30+ min)24$3,281$122
Short return visit27$1,586$51

2021: 3 services

Original Medicare services billed in 2021
Short return visit (20+ min)43$3,506$75
Cervical or vaginal cancer screening; pelvic and clinical breast examination45$2,030$45
Short return visit23$1,096$41

2020: 3 services

Original Medicare services billed in 2020
Short return visit (20+ min)39$2,637$59
Cervical or vaginal cancer screening; pelvic and clinical breast examination51$2,293$45
Short return visit25$879$29

2019: 4 services

Original Medicare services billed in 2019
Cervical or vaginal cancer screening; pelvic and clinical breast examination64$2,775$43
Short return visit (20+ min)33$2,220$58
Short return visit28$1,387$37
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory11$553$50

2018: 5 services

Original Medicare services billed in 2018
Cervical or vaginal cancer screening; pelvic and clinical breast examination60$2,630$44
Short return visit (20+ min)30$2,004$59
Short return visit35$1,863$37
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory27$1,427$53
Urinalysis, manual test11$44$3

2017: 7 services

Original Medicare services billed in 2017
Cervical or vaginal cancer screening; pelvic and clinical breast examination61$2,682$44
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory28$1,481$53
Short return visit (20+ min)16$1,326$63
Short return visit18$1,086$36
Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous36$770$21
Office for the evaluation and management of established patient that may not require presence of healthcare professional13$210$16
Urinalysis, manual test14$48$3

2016: 5 services

Original Medicare services billed in 2016
Cervical or vaginal cancer screening; pelvic and clinical breast examination55$2,407$44
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory39$2,077$53
Short return visit (20+ min)21$1,278$53
Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous53$1,126$21
Short return visit22$1,090$36

2015: 5 services

Original Medicare services billed in 2015
Cervical or vaginal cancer screening; pelvic and clinical breast examination78$3,417$44
Short return visit (20+ min)38$2,756$59
Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous68$1,443$21
Short return visit19$834$36
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory12$640$53

2014: 5 services

Original Medicare services billed in 2014
Short return visit (20+ min)26$2,671$61
Cervical or vaginal cancer screening; pelvic and clinical breast examination35$1,504$43
Return visit (30+ min)14$1,343$90
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory22$1,144$52
Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous45$957$21

2013: 5 services

Original Medicare services billed in 2013
Cervical or vaginal cancer screening; pelvic and clinical breast examination59$2,541$43
Short return visit (20+ min)32$2,383$57
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory37$1,969$53
Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous55$1,183$22
Return visit (30+ min)11$896$81

Drugs they prescribed that Part D paid

$41,189

Pharmacies billed $41,189 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 391) in 2024. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0%.

352 generic and 39 brand-name prescriptions · $41,189 in drug cost · 26 antibiotic prescriptions to 16 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Estradiol107$13,344$125
Yuvafem24$3,738$156
Estradiol (Twice Weekly)35$3,696$106
Dotti26$3,332$128
Valacyclovir33$2,782$84
See all 9 drugs
Every Part D drug this clinician prescribed
Estradiol107$13,344$125
Yuvafem24$3,738$156
Estradiol (Twice Weekly)35$3,696$106
Dotti26$3,332$128
Valacyclovir33$2,782$84
Progesterone48$1,371$29
Clobetasol Propionate12$645$54
Nitrofurantoin Mono-Macro12$193$16
Fluconazole11$76$7

Year by year

Part D prescribing by year
20243911460% (0)10%$41,189
2023344124None22%$43,677
2022363113None22%$45,458
2021312950% (0)None$36,870
2020354950% (0)15%$43,078
201935987None20%$40,990
201828176None17%$34,891
201723859None29%$31,429
201620056None36%$22,212
201518948None39%$22,813
2014175440% (0)None$19,658
201311232None39%$8,914

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 12 drugs

Part D drugs prescribed in 2023
Estring19$10,234$539
Estradiol68$7,867$116
Estradiol (Twice Weekly)36$6,231$173
Yuvafem15$3,359$224
Valacyclovir26$2,132$82
Dotti11$1,713$156
Progesterone26$1,010$39
Clobetasol Propionate11$499$45
Fluconazole20$395$20
Nitrofurantoin Mono-Macro12$298$25
Acyclovir12$252$21
Triamcinolone Acetonide13$54$4

2022: 9 drugs

Part D drugs prescribed in 2022
Estring18$9,041$502
Estradiol85$8,964$105
Estradiol (Twice Weekly)49$7,396$151
Valacyclovir32$2,689$84
Progesterone34$1,180$35
Dotti15$1,030$69
Clobetasol Propionate16$626$39
Acyclovir14$587$42
Fluconazole15$170$11

2021: 8 drugs

Part D drugs prescribed in 2021
Estradiol66$6,845$104
Estradiol (Twice Weekly)34$4,561$134
Valacyclovir36$2,752$76
Dotti14$1,078$77
Progesterone17$1,067$63
Acyclovir15$482$32
Nitrofurantoin Mono-Macro12$292$24
Fluconazole16$184$11

2020: 8 drugs

Part D drugs prescribed in 2020
Estradiol88$10,049$114
Estradiol (Twice Weekly)27$4,806$178
Valacyclovir38$3,387$89
Dotti12$1,390$116
Progesterone18$1,308$73
Acyclovir20$885$44
Medroxyprogesterone Acetate18$293$16
Fluconazole25$196$8

2019: 9 drugs

Part D drugs prescribed in 2019
Estradiol120$13,927$116
Premarin11$3,639$331
Yuvafem13$3,576$275
Valacyclovir47$2,640$56
Progesterone33$2,125$64
Clobetasol Propionate17$932$55
Medroxyprogesterone Acetate18$244$14
Fluconazole13$214$16
Acyclovir11$139$13

2018: 7 drugs

Part D drugs prescribed in 2018
Estradiol72$7,510$104
Yuvafem30$6,931$231
Premarin12$4,206$351
Valacyclovir48$1,926$40
Progesterone15$1,322$88
Medroxyprogesterone Acetate15$200$13
Fluconazole15$164$11

2017: 6 drugs

Part D drugs prescribed in 2017
Vagifem20$6,529$326
Premarin17$5,788$340
Estrace15$4,835$322
Estradiol41$2,999$73
Valacyclovir45$1,375$31
Fluconazole17$165$10

2016: 5 drugs

Part D drugs prescribed in 2016
Vagifem23$5,476$238
Estradiol43$3,014$70
Diflucan14$2,527$180
Valacyclovir20$754$38
Medroxyprogesterone Acetate15$240$16

2015: 5 drugs

Part D drugs prescribed in 2015
Vagifem26$7,773$299
Estradiol43$1,981$46
Diflucan15$1,882$125
Valacyclovir14$987$70
Medroxyprogesterone Acetate11$188$17

2014: 6 drugs

Part D drugs prescribed in 2014
Vagifem34$5,956$175
Vivelle-Dot16$2,277$142
Estrace12$2,156$180
Valacyclovir16$1,426$89
Estradiol20$333$17
Medroxyprogesterone Acetate13$197$15

2013: 4 drugs

Part D drugs prescribed in 2013
Vagifem16$2,308$144
Vivelle-Dot13$1,108$85
Estradiol23$752$33
Fluconazole20$296$15

Money from drug and device companies

$32 in 2025

Industry payments by year
202522None$32
202411None$3
202323None$46
202211None$27
202111None$12
202011None$14
201911None$16

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
BiogenZurzuvae$29
1 payment
  • Meals for Zurzuvae · 2025-07-09 · $29
Mayne Pharma CommercialNone$3
1 payment
  • Meals · 2025-07-29 · $3
See all 2 published payments
Every published payment
Mayne Pharma CommercialMeals · 2025-07-29None$3
BiogenMeals · 2025-07-09Zurzuvae$29
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)

2024: $3

Payments by company in 2024
Mayne Pharma CommercialNone$3
1 payment
  • Meals · 2024-02-27 · $3

2023: $46

Payments by company in 2023
Astellas Pharma USVeozah$26
1 payment
  • Meals for Veozah · 2023-06-21 · $26
Mayne Pharma CommercialNone$20
2 payments
  • Meals · 2023-07-25 · $6
  • Meals · 2023-04-04 · $14

2022: $27

Payments by company in 2022
AbbvieOrilissa$27
1 payment
  • Meals for Orilissa · 2022-08-24 · $27

2021: $12

Payments by company in 2021
CooperSurgicalParagard$12
1 payment
  • Meals for Paragard · 2021-01-12 · $12

2020: $14

Payments by company in 2020
Avion PharmaceuticalsBalcoltra$14
1 payment
  • Meals for Balcoltra · 2020-08-15 · $14

2019: $16

Payments by company in 2019
TherapeuticsMDImvexxy$16
1 payment
  • Meals for Imvexxy · 2019-05-14 · $16

Professional record

NPI
1285731703
Licence
CA A64736California A64736: Current · expires 2028-04-30
Trained
University of California, Geffen School of Medicine, 1996 · 30 years ago
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
Yes
Taxonomy
Federal specialty code 207V00000X (207V00000X)
Mailing address
5 Bon Air Rd, Suite 117, Larkspur, CA, 94939
NPI first listed
2006-09-19
NPI last updated
2007-07-08

This is when the NPI record was last certified, not a medical board exam.